XML 145 R27.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Earnings Per Share (Exelon) | 12 Months Ended
--- | ---
Dec. 31, 2018
Earnings Per Share [Abstract] |
Earnings Per Share (Exelon) | Earnings Per Share (Exelon) Basic earnings per share is computed by dividing net income attributable to common stockholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income attributable to common shareholders by the weighted average number of common shares outstanding, including the effect of issuing common stock assuming (i) stock options are exercised, and (ii) performance share awards and restricted stock awards are fully vested under the treasury stock method. The following table sets forth the components of basic and diluted earnings per share and shows the effect of these stock options, performance share awards and restricted stock awards on the weighted average number of shares outstanding used in calculating diluted earnings per share:
| Year Ended December 31,
| 2018 |  | 2017 |  | 2016
Net income attributable to common shareholders | $ | 2,010 |  |  | $ | 3,786 |  |  | $ | 1,121 |
Weighted average common shares outstanding — basic | 967 |  |  | 947 |  |  | 924 |
Assumed exercise and/or distributions of stock-based awards | 2 |  |  | 2 |  |  | 3 |
Weighted average common shares outstanding — diluted | 969 |  |  | 949 |  |  | 927 |
The number of stock options not included in the calculation of diluted common shares outstanding due to their antidilutive effect was approximately 3 million in 2018, 8 million in 2017, and 12 million in 2016. There were no equity units related to the PHI merger not included in the calculation of diluted common shares outstanding due to their antidilutive effect for the years ended December 31, 2018, 2017, and 2016. See Note 18 — Shareholders' Equity for additional information regarding the equity units and equity forward units. On June 1, 2017, Exelon settled the forward purchase contract, which was a component of the June 2014 equity units, through the issuance of approximately 33 million shares of Exelon common stock from treasury stock. The issuance of shares on June 1, 2017 triggered full dilution in the EPS calculation, which prior to settlement were included in the calculation of diluted EPS using the treasury stock method. See Note 18 — Shareholders' Equity for additional information regarding share repurchases.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration